Table of Contents
Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.4 List of Abbreviations
Chapter 2 Executive Summary
Chapter 3 Global Artificial Vital Organs and Medical Bionics Market Overview
3.1 Introduction
3.2 Market Trends and Future Outlook
3.3 Market Drivers
3.3.1 Increase in Prevalence of Organ Failure and Disabilities
3.3.2 Increase in the Number of Patients for Organ Transplant and Lack Of Donor Organs
3.4 Market Restraints
3.4.1 Criticism Associated with Artificial Organ Transplant
3.4.2 High Cost Involved in Development of Artificial Organs and Medical Bionics
3.5 Market Opportunities
3.5.1 Scope Of Artificial Organs in Therapeutics
3.6 Porter’s Five Force Analysis: Global Artificial Vital Organs & Medical Bionics Market
3.6.1 Bargaining Power of Suppliers
3.6.2 Bargaining Power of Buyers
3.6.3 Threat from Substitutes
3.6.4 Threat of New Entrants
3.6.5 Degree of Competitive Rivalry
3.7 Market Attractiveness Analysis: Global Artificial Vital Organs and Medical Bionics Market, By Geography
Chapter 4 Global Artificial Vital Organs and Medical Bionics Market, By Product Type
4.1 Overview
4.2 Artificial Vital Organs Market
4.2.1 Artificial Heart
4.2.1.1 Total Artificial Heart (TAH)
4.2.2 Artificial Kidney
4.2.2.1 Hemodialysis Machines
4.2.3 Artificial Liver
4.2.4 Artificial Pancreas
4.2.4.1 Insulin Pumps
4.2.5 Artificial Lungs
4.2.5.1 Heart-Lung Bypass Machines
4.2.5.2 Oxygenators
4.3 Bionics Market
4.3.1 Ear Bionics (Cochlear Implants)
4.3.2 Vision Bionics
4.3.3 Exoskeletons
4.3.4 Bionic Limbs
4.3.4.1 Bionic Leg
4.3.4.2 Bionic Hand
4.3.5 Brain Bionics
4.3.5.1 Spinal Cord Stimulators
4.3.5.2 Deep Brain Stimulators
4.3.5.3 Vagus Nerve Stimulators
4.3.6 Cardiac Bionics
4.3.6.1 Ventricular Assist Device (VAD)
4.3.6.2 Left Ventricular Assist Device (LVAD)
4.3.6.3 Right Ventricular Assist Device (RVAD)
4.3.6.4 Heart Valves
4.3.6.4.1 Mechanical Heart Valves
4.3.6.4.2 Biological Tissue Valves
4.3.6.4.3 Transcatheter Heart Valves
Chapter 5 Global Artificial Vital Organs and Medical Bionics Market, By Geography
5.1 Introduction
5.2 North America
5.2.1 North America Artificial Vital Organs and Medical Bionics Market, Size and Forecast, 2010 – 2018 (USD Million)
5.3 Europe
5.3.1 Europe Artificial Vital Organs and Medical Bionics Market, Size and Forecast, 2010 – 2018 (USD Million)
5.4 Asia-Pacific
5.4.1 Asia-Pacific Artificial Vital Organs and Medical Bionics Market, Size and Forecast, 2010 – 2018 (USD Million)
5.5 Rest of the World (Row)
5.5.1 Row Artificial Vital Organs and Medical Bionics Market, Size and Forecast, 2010 – 2018 (USD Million)
Chapter 6 Competitive Landscape
6.1 Current Market Scenario and Pipeline Snapshot
Chapter 7 Recommendations
7.1 Market Strategy for Success
7.2 Barriers to be Considered
7.2.1 Financial Constraints
7.2.2 Regulatory Approvals
Chapter 8 Company Profiles
8.1 Abbott Diabetes Care, Inc.
8.1.1 Company Overview
8.1.2 Financial Overview
8.1.3 Product Portfolio
8.1.4 Strategic Overview
8.1.5 Recent Developments
8.2 Abiomed, Inc.
8.2.1 Company Overview
8.2.2 Financial Overview
8.2.3 Product Portfolio
8.2.4 Strategic Overview
8.2.5 Recent Developments
8.3 Asahi Kasei Medical Co., Ltd.
8.3.1 Company Overview
8.3.2 Financial Overview
8.3.3 Product Portfolio
8.3.4 Strategic Overview
8.3.5 Recent Developments
8.4 Baxter International, Inc.
8.4.1 Company Overview
8.4.2 Financial Overview
8.4.3 Product Portfolio
8.4.4 Strategic Overview
8.4.5 Recent Developments
8.5 Cyberonics, Inc.
8.5.1 Company Overview
8.5.2 Financial Overview
8.5.3 Product Portfolio
8.5.4 Strategic Overview
8.5.5 Recent Developments
8.6 Edwards Lifesciences Corporation
8.6.1 Company Overview
8.6.2 Financial Overview
8.6.3 Product Portfolio
8.6.4 Strategic Overview
8.6.5 Recent Developments
8.7 Ekso Bionics
8.7.1 Company Overview
8.7.2 Financial Overview
8.7.3 Product Portfolio
8.7.4 Strategic Overview
8.7.5 Recent Developments
8.8 F. Hoffmann-La Roche Ltd
8.8.1 Company Overview
8.8.2 Financial Overview
8.8.3 Product Portfolio
8.8.4 Strategic Overview
8.8.5 Recent Developments
8.9 Fresenius Medical Care AG & Co. Kgaa
8.9.1 Company Overview
8.9.2 Financial Overview
8.9.3 Product Portfolio
8.9.4 Strategic Overview
8.9.5 Recent Developments
8.10 Gambro AB
8.10.1 Company Overview
8.10.2 Financial Overview
8.10.3 Product Portfolio
8.10.4 Strategic Overview
8.10.5 Recent Developments
8.11 Iwalk, Inc.
8.11.1 Company Overview
8.11.2 Financial Overview
8.11.3 Product Portfolio
8.11.4 Strategic Overview
8.11.5 Recent Developments
8.12 Jarvik Heart, Inc.
8.12.1 Company Overview
8.12.2 Financial Overview
8.12.3 Product Portfolio
8.12.4 Strategic Overview
8.12.5 Recent Developments
8.13 Medtronic, Inc.
8.13.1 Company Overview
8.13.2 Financial Overview
8.13.3 Product Portfolio
8.13.4 Strategic Overview
8.13.5 Recent Developments
8.14 Micromed Cardiovascular, Inc.
8.14.1 Company Overview
8.14.2 Financial Overview
8.14.3 Product Portfolio
8.14.4 Strategic Overview
8.14.5 Recent Developments
8.15 Nikkiso Co., Ltd.
8.15.1 Company Overview
8.15.2 Financial Overview
8.15.3 Product Portfolio
8.15.4 Strategic Overview
8.15.5 Recent Developments
8.16 Ossur Hf
8.16.1 Company Overview
8.16.2 Financial Overview
8.16.3 Product Portfolio
8.16.4 Strategic Overview
8.16.5 Recent Developments
8.17 Ottobock Healthcare Gmbh
8.17.1 Company Overview
8.17.2 Financial Overview
8.17.3 Product Portfolio
8.17.4 Strategic Overview
8.17.5 Recent Developments
8.18 Second Sight Medical Products, Inc.
8.18.1 Company Overview
8.18.2 Financial Overview
8.18.3 Product Portfolio
8.18.4 Strategic Overview
8.18.5 Recent Developments
8.19 Syncardia Systems, Inc.
8.19.1 Company Overview
8.19.2 Financial Overview
8.19.3 Product Portfolio
8.19.4 Strategic Overview
8.19.5 Recent Developments
8.20 Thoratec Corporation
8.20.1 Company Overview
8.20.2 Financial Overview
8.20.3 Product Portfolio
8.20.4 Strategic Overview
8.20.5 Recent Developments
8.21 Touch Bionics, Inc.
8.21.1 Company Overview
8.21.2 Financial Overview
8.21.3 Product Portfolio
8.21.4 Strategic Overview
8.21.5 Recent Developments
8.22 Vital Therapies, Inc.
8.22.1 Company Overview
8.22.2 Financial Overview
8.22.3 Product Portfolio
8.22.4 Strategic Overview
8.22.5 Recent Developments
8.23 Worldheart Corporation
8.23.1 Company Overview
8.23.2 Financial Overview
8.23.3 Product Portfolio
8.23.4 Strategic Overview
8.23.5 Recent Developments
List of Tables
TABLE 1 Market Snapshot: Global Artificial Vital Organs and Medical Bionics Market
TABLE 2 Global Artificial Vital Organs and Medical Bionics Market, By Product Type, Size and Forecast, 2010 – 2018 (USD Million)
TABLE 3 Global Artificial Lungs Market, By Product Type, Size and Forecast, 2010 – 2018 (USD Million)
TABLE 4 Global Medical Bionics Market, By Product Type, Size and Forecast, 2010 – 2018 (USD Million)
TABLE 5 Global Bionic Limbs Market, By Product Type, Size and Forecast, 2010 -2018 (USD Million)
TABLE 6 Global Brain Bionics Market, By Product Type, Size and Forecast, 2010 – 2018 (USD Million)
TABLE 7 Global Cardiac Bionics Market, By Product Type, Size and Forecast, 2010 – 2018 (USD Million)
TABLE 8 Global Ventricular Assist Devices (VAD) Market, By Product Type, Size and Forecast, 2010 – 2018 (USD Million)
TABLE 9 Global Heart Valves Market, By Product Type, Market Size and Forecast, 2010 – 2018 (USD Million)
TABLE 10 Global Artificial Vital Organs And Medical Bionics Market, By Geography, Size and Forecast, 2010 – 2018 (USD Million)
TABLE 11 Competitive Landscape: Global Artificial Vital Organs Market
TABLE 12 Competitive Landscape: Global Medical Bionics Market
List of Figures
FIG. 1 Artificial Vital Organs and Medical Bionics: Market Segmentation
FIG. 2 Global Artificial Vital Organs Market, By Product Type, 2011 (USD Million)
FIG. 3 Global Medical Bionics Market, By Product Type, 2011 (USD Million)
FIG. 4 Global Artificial Vital Organs and Medical Bionics Market, Size and Forecast, 2010 – 2018 (USD Million)
FIG. 5 Porter’s Five Force Analysis: Global Artificial Vital Organs & Medical Bionics Market
FIG. 6 Market Attractiveness Analysis: Global Artificial Vital Organs and Medical Bionics Market, By Geography
FIG. 7 Comparative Analysis: Global Artificial Vital Organs Market, By Product Type, 2011 & 2018 (Value %)
FIG. 8 Global Artificial Vital Organs Market, Size and Forecast, 2010 – 2018 (USD Million)
FIG. 9 Global Total Artificial Heart (TAH) Market, Size and Forecast, 2010 – 2018 (USD Million)
FIG. 10 Global Hemodialysis Machines Market, Size and Forecast, 2010 – 2018 (USD Million)
FIG. 11 Global Artificial Liver Market, Size and Forecast, 2010 – 2018 (USD Million)
FIG. 12 Global Insulin Pumps Market, Size and Forecast, 2010 – 2018 (USD Million)
FIG. 13 Global Heart-Lung Bypass Machines Market, Size and Forecast, 2010 – 2018 (USD Million)
FIG. 14 Global Oxygenators, Market Size and Forecast, 2010 – 2018 (USD Million)
FIG. 15 Comparative Analysis: Global Medical Bionics Market, By Product Type, 2011 & 2018 (Value %)
FIG. 16 Global Ear Bionics (Cochlear Implants) Market, Size and Forecast, 2010 – 2018 (USD Million)
FIG. 17 Global Vision Bionics Market, Size and Forecast, 2010 – 2018 (USD Million)
FIG. 18 Global Exoskeletons Market, Size and Forecast, 2010 – 2018 (USD Million)
FIG. 19 Global Bionic Leg Market, Size and Forecast, 2010 – 2018 (USD Million)
FIG. 20 Global Bionic Hand Market, Size and Forecast, 2010 – 2018 (USD Million)
FIG. 21 Global Spinal Cord Stimulators Market, Size and Forecast, 2010 – 2018 (USD Million)
FIG. 22 Global Deep Brain Stimulators Market, Size and Forecast, 2010 – 2018 (USD Million)
FIG. 23 Global Vagus Nerve Stimulators Market, Size and Forecast, 2010 – 2018 (USD Million)
FIG. 24 Global Left Ventricular Assist Device (LVAD) Market, Size and Forecast, 2010 – 2018 (USD Million)
FIG. 25 Global Right Ventricular Assist Device (RVAD) Market, Size and Forecast, 2010 – 2018 (USD Million)
FIG. 26 Global Mechanical Heart Valves Market, Size and Forecast, 2010 – 2018 (USD Million)
FIG. 27 Global Biological Tissue Valves Market, Size and Forecast, 2010 – 2018 (USD Million)
FIG. 28 Global Transcatheter Heart Valves Market, Size and Forecast, 2010 – 2018 (USD Million)
FIG. 29 Comparative Analysis: Global Artificial Vital Organs and Medical Bionics Market, By Geography, 2011 & 2018 (Value %)
FIG. 30 North America Artificial Vital Organs And Medical Bionics Market, Size and Forecast, 2010 – 2018 (USD Million)
FIG. 31 Europe Artificial Vital Organs And Medical Bionics Market, Size and Forecast, 2010 – 2018 (USD Million)
FIG. 32 Asia-Pacific Artificial Vital Organs And Medical Bionics Market, Size and Forecast, 2010 – 2018 (USD Million)
FIG. 33 Row Artificial Vital Organs And Medical Bionics Market, Size and Forecast, 2010 – 2018 (USD Million)
FIG. 34 Abbott Diabetes Care, Inc.: Annual Revenues, 2010 – 2012 (USD Million)
FIG. 35 Abiomed, Inc.: Annual Revenues, 2010 – 2012 (USD Million)
FIG. 36 Asahi Kasei Corporation (Healthcare Segment): Annual Revenues, 2010 – 2012 (USD Million)
FIG. 37 Baxter International, Inc.: Annual Revenues, 2010 – 2012 (USD Million)
FIG. 38 Cyberonics, Inc.: Annual Revenues, 2010 – 2012 (USD Million)
FIG. 39 Edwards Lifesciences Corporation: Annual Revenues, 2010 – 2012 (USD Million)
FIG. 40 F. Hoffmann-La Roche Ltd: Annual Revenues, 2010 – 2012 (USD Million)
FIG. 41 Fresenius Medical Care AG & Co. Kgaa: Annual Revenues, 2010 – 2012 (USD Million)
FIG. 42 Medtronic, Inc.: Annual Revenues, 2010 – 2012 (USD Million)
FIG. 43 Nikkiso Co. Ltd.: Annual Revenues, 2010 – 2012 (USD Million)
FIG. 44 Ossur Hf: Annual Revenues, 2010 – 2012 (USD Million)
FIG. 45 Thoratec Corporation: Annual Revenues, 2010 – 2012 (USD Million)